Physician profile
Jin Hee Kim
NPI 1043207871
$4,681.68
in general payments reported to CMS, 2019-2025
38 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $888 · 2020: $337 · 2021: $92.97 · 2022: $349 · 2023: $770 · 2024: $1,067 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,831 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,830.58 |
| Education | $184.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $721.68 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $525.90 | 2019-2025 | |
| Boston Scientific Corporation | $383.23 | 2019-2025 | Axonics, Rezum Generator |
| Abbvie INC. | $342.31 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $336.89 | 2023-2025 | Gemtesa |
| Intuitive Surgical, INC. | $303.21 | 2019-2025 | |
| Coloplast Corp | $242.47 | 2020-2025 | Self-Cath, Saffron |
| Axonics, INC. | $210.44 | 2020-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $163.53 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $153.03 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Convatec INC. | $109.90 | 2023-2025 | |
| Accord Healthcare, INC. | $106.29 | 2023-2025 | |
| Tolmar, INC. | $104.59 | 2023-2024 | |
| Janssen Biotech, INC. | $92.44 | 2019-2025 | |
| Angiodynamics, INC. | $85.32 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $70.58 | 2019 | |
| Myriad Genetic Laboratories, INC. | $69.24 | 2022-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $69.03 | 2022-2023 | Provenge |
| Ferring Pharmaceuticals INC. | $65.83 | 2019-2025 | Adstiladrin |
| 180 Medical, INC. | $58.82 | 2024-2025 | Cure Catheter |
| Urogen Pharma, INC. | $49.75 | 2023-2025 | Jelmyto |
| Myovant Sciences INC. | $47.92 | 2021 | |
| Progenics Pharmaceuticals, INC. | $47.35 | 2024-2025 | |
| Ethicon US, LLC | $37.89 | 2024 | Echelon; Endopath, Echelon Flex |
| Caldera Medical, INC | $31.59 | 2023 | Desara |
| Travere Therapeutics, INC. | $27.35 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $26.00 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $25.36 | 2023 | Lynparza |
| Covidien LP | $21.65 | 2019 | |
| Olympus America INC. | $20.94 | 2025 | Itind System |
| Antares Pharma, INC. | $18.75 | 2020 | |
| Solventum Corporation | $18.52 | 2025 | Activ.A.C. |
| Urovant Sciences INC | $17.28 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.06 | 2024 | |
| Valencia Technologies Corporation | $17.05 | 2025 | Ecoin Device Kit |
| Therapeuticsmd, INC. | $14.82 | 2019 | |
| Becton, Dickinson and Company | $14.60 | 2019 | |
| Immunitybio, INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Hee Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.